AngioDynamics’ history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach. Queensbury was chosen due to its location in the heart of "Catheter Valley," an area in New York's Adirondack Region named for its long history of catheter and other medical device manufacturing. Today, the Company has made its presence apparent far beyond Upstate New York with 1,300 employees worldwide at facilities in the United States, Europe, and Asia. AngioDynamics is currently selling in more than 50 markets through direct sales and distributors.
Initially dedicated to the research and development of products used in interventional radiology, the Company soon became well established as a producer of diagnostic catheters for non-coronary angiography and thrombolytic delivery systems. Through acquisitions of companies such as RITA Medical Systems in January 2007, Oncobionic in May 2008, and the assets of Diomed in June 2008 and FlowMedica in January 2009, AngioDynamics now boasts a diverse product line that includes market-leading thermal and non-thermal ablation systems, vascular access products, angiographic products and accessories, dialysis products, drainage products, thrombolytic products, venous products and targeted renal therapy products.
Continuing its expansion, in May 2012, AngioDynamics acquired Navilyst Medical, bringing market-leading fluid management systems into its portfolio. The acquisition significantly expanded the Company's scale, doubling its share of the vascular access market while building critical mass in the peripheral vascular market. A comprehensive look at the Company's history can be found in the form of an interactive timeline of events at www.angiodynamics.com.
Initially dedicated to the research and development of products used in interventional radiology, the Company soon became well established as a producer of diagnostic catheters for non-coronary angiography and thrombolytic delivery systems. Through acquisitions of companies such as RITA Medical Systems in January 2007, Oncobionic in May 2008, and the assets of Diomed in June 2008 and FlowMedica in January 2009, AngioDynamics now boasts a diverse product line that includes market-leading thermal and non-thermal ablation systems, vascular access products, angiographic products and accessories, dialysis products, drainage products, thrombolytic products, venous products and targeted renal therapy products.
Continuing its expansion, in May 2012, AngioDynamics acquired Navilyst Medical, bringing market-leading fluid management systems into its portfolio. The acquisition significantly expanded the Company's scale, doubling its share of the vascular access market while building critical mass in the peripheral vascular market. A comprehensive look at the Company's history can be found in the form of an interactive timeline of events at www.angiodynamics.com.
Location: Australia, Australian Capital Territory, Latham
Employees: 501-1000
Phone: +1 518-795-1400
Founded date: 1988
Investors 1
| Date | Name | Website |
| - | Avista Cap... | avistacap.... |
Mentions in press and media 18
| Date | Title | Description |
| 06.02.2026 | AngioDynamics Launches Investigator-Led Pulmonary Embolism Research Fund With PERT Consortium | AngioDynamics, a vascular-focused medical technology company, and The PERT Consortium, a multidisciplinary organization focused on improving pulmonary embolism care, have launched the ALPHA-PE Research Fund, an investigator-led program to s... |
| 05.08.2025 | Glasgow MedTech Novosound Targets FDA Clearance with New Exec Appointment | Glasgow-headquartered medtech Novosound has announced the appointment of renowned medical technology executive Gary Beale as executive vice chairman. In this role, Beale will lead the company’s medical business as novosound moves towards FD... |
| 31.10.2024 | Dr. Ali Afshar Opens New Urology Practice in Beverly Hills, Providing Advanced Men's and Prostate Health Care | Dr. Ali Afshar Dr. Ali Afshar, a board-certified urologist, has opened a new practice, Dr. Ali Afshar, M.D. Men's and Prostate Health, in Beverly Hills, CA, offering advanced and compassionate urological care for men's and prostate health. ... |
| 03.09.2024 | AngioDynamics wins CE mark for atherectomy system | The Auryon atherectomy system console. [Image from AngioDynamics]AngioDynamics (Nasdaq:ANGO) announced today that it received CE mark approval for its Auryon atherectomy system. Latham, New York-based AngioDynamics designed Auryon for the t... |
| 27.02.2024 | AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of Immunotherapy | LATHAM, NEW YORK, February 27, 2024 /EINPresswire.com/ -- AngioDynamics, Inc. (NASDAQ: ANGO), a global provider of medical devices, and Immunophotonics, Inc., a clinical-stage biopharma company focused on immuno-oncology, are pleased to ann... |
| 12.08.2021 | AngioDynamics : Receives FDA Approval for PRESERVE Study | Study Will Assess Use of NanoKnife System in Prostate Tissue Ablation Latham, New York, August 11, 2021 - AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripher... |
| 04.10.2019 | AngioDynamics Buys Eximo Medical, for Up To 66M | AngioDynamics, Inc. (NASDAQ: ANGO), a Latham, NY-based provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, acquired Eximo Medical, Ltd., a Rehovot, Israel-based early co... |
| 06.04.2017 | AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders | Albany, NY, April 06, 2017 – (GLOBE NEWSWIRE) — AngioDynamics, Inc. (NASDAQ:ANGO) (the “Company”), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, ... |
| 27.08.2012 | Device startup aims to reduce blood loss, procedure times in liver resection for cancer patients | Medical Engineering Innovations (MEI) hopes that its new device with its blade-shaped electrode boasting a larger array, ability to coagulate large blood vessels and unique algorithms for delivering RF energy, will make liver resections les... |
| 31.01.2012 | AngioDynamics to Acquire Navilyst Medical for $372 Million | Increases Scale in Vascular Access and Peripheral Vascular Markets Expands Product Portfolio and Adds Innovative Technologies Strengthens Focus on Operational Excellence Expected to be Accretive in FY13 ALBANY, N.Y. and MARLBOROUGH, Mass.,... |
Show more